Friday, September 25th | 7 Tishri 5781

July 22, 2020 2:06 pm

Israel Hosts US Envoy at Biochem Lab, Seeks FDA Nod for Coronavirus Vaccine Prototype

avatar by Reuters and Algemeiner Staff

Scientists at work in laboratory. Photo: Wikimedia Commons.

The US ambassador to Israel visited its bio-chemical defense laboratory and was briefed on a coronavirus vaccine prototype for which it is seeking US Food and Drug Administration (FDA) regulation, a US official said on Wednesday.

The vaccine being developed at the Israel Institute for Biological Research (IIBR), in Ness Ziona, began animal trials in March. A source familiar with IIBR activities said human trials were expected before year’s end.

A US official described Ambassador David Friedman’s visit to the IIBR on Monday as part of the two allies’ “robust fight against the coronavirus.”

Israel‘s Defense Ministry, which oversees the IIBR, had no immediate comment.

Related coverage

September 25, 2020 9:45 am

Israeli Minister Outlines Plan to Foster Stronger Unity Among Diaspora Jewry - Following the adoption of the Israeli government’s plan earlier this summer to help ensure unity of the global...

The IIBR is seeking FDA vaccine regulation, the US official added. Asked whether Friedman would help in this regard, the official said only that the envoy was “working tirelessly to ensure that things that (can) help the American people can get to them in the most effective and efficient way.”

The FDA website says its “regulations for the development of vaccines ensure their safety, purity, potency and effectiveness” and could pave the way for a vaccine’s use in the United States.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.